FIORCARI, STEFANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.142
EU - Europa 1.212
AS - Asia 255
SA - Sud America 7
OC - Oceania 2
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.620
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.129
GB - Regno Unito 525
IT - Italia 218
SE - Svezia 161
DE - Germania 102
CN - Cina 87
HK - Hong Kong 76
UA - Ucraina 60
TR - Turchia 46
FI - Finlandia 41
BG - Bulgaria 28
FR - Francia 21
SG - Singapore 20
BE - Belgio 18
CA - Canada 10
VN - Vietnam 9
RU - Federazione Russa 8
ES - Italia 7
JP - Giappone 6
RO - Romania 6
CL - Cile 4
NL - Olanda 4
BZ - Belize 3
CZ - Repubblica Ceca 3
IE - Irlanda 3
IN - India 3
MY - Malesia 3
AU - Australia 2
BR - Brasile 2
DK - Danimarca 2
HR - Croazia 2
IR - Iran 2
AM - Armenia 1
AR - Argentina 1
AT - Austria 1
DZ - Algeria 1
EU - Europa 1
GR - Grecia 1
ID - Indonesia 1
PK - Pakistan 1
PL - Polonia 1
Totale 4.620
Salva come PNG Salva come JPEG
Città #
Fairfield 521
Southend 446
Woodbridge 294
Ashburn 274
Chandler 254
Houston 244
Cambridge 208
Seattle 205
Wilmington 155
Ann Arbor 151
Nyköping 133
Dearborn 108
Modena 103
Jacksonville 102
Hong Kong 76
New York 46
Fremont 42
Beijing 33
San Diego 30
Izmir 29
Princeton 29
Sofia 28
Bremen 26
Eugene 26
Helsinki 22
Brussels 18
London 15
Redwood City 15
Bologna 12
Falls Church 9
Phoenix 9
San Jose 9
Boardman 8
Dong Ket 8
Milan 8
San Giuliano Milanese 7
Castelnuovo Rangone 6
Chicago 6
Des Moines 6
Madrid 6
Shanghai 6
Guangzhou 5
Hefei 5
Kilburn 4
Kunming 4
Norwalk 4
Ottawa 4
San Francisco 4
Amsterdam 3
Atlanta 3
Belize City 3
Castelnovo ne' Monti 3
Clearwater 3
Dublin 3
Las Vegas 3
Leawood 3
Los Angeles 3
Reggio Emilia 3
Toronto 3
Verona 3
Albuquerque 2
Ancona 2
Boretto 2
Chiswick 2
Constanta 2
Dallas 2
Dongguan 2
Fasano 2
Freiburg 2
Fukushima 2
Fuzhou 2
Hounslow 2
Indiana 2
Jinan 2
Lappeenranta 2
Martina Franca 2
Montréal 2
Munich 2
Parma 2
Saint Louis 2
Santiago 2
Shenyang 2
Southwark 2
São Paulo 2
Timisoara 2
Tokushima 2
Trento 2
Udine 2
Wandsworth 2
Zagreb 2
Athens 1
Baotou 1
Berlin 1
Bomporto 1
Bonn 1
Brno 1
Calcinaia 1
Capoterra 1
Carmignano di Brenta 1
Carpi 1
Totale 3.869
Salva come PNG Salva come JPEG
Nome #
Monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation 398
Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia 235
The histone deacetylase inhibitor romidepsin synergizes with lenalidomide and enhances tumor cell death in T-cell lymphoma cell lines 228
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 219
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through eta receptor 203
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide 201
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 195
Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas 192
Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib 184
The expression of endothelin-1 in chronic lymphocytic leukemia is controlled by epigenetic mechanisms and extracellular stimuli. 180
Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile on leukemic cells. 179
ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia 179
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia 170
The PI3-kinase delta inhibitor idelalisib (GS-1101) targets integrin-mediated adhesion of chronic lymphocytic leukemia (CLL) cell to endothelial and marrow stromal cells 168
Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia. 165
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 164
Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement 163
Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF. 163
Lenalidomide in chronic lymphocytic leukemia: The present and future in the era of tyrosine kinase inhibitors 147
Overexpression of CD49d in trisomy 12 chronic lymphocytic leukemia patients is mediated by IRF4 through induction of IKAROS 143
Immunomodulatory effect of ibrutinib: Reducing the barrier against fungal infections 141
Selective inhibition of PI3Kγ affects survival and proliferation of chronic lymphocytic leukemia B cells 132
Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone. 125
INTERACTION BETWEEN ENDOTHELIUM AND CHRONIC LYMPHOCYTIC LEUKEMIA B-CELLS RESCUES FROM APOPTOSIS AND MODULATES GENE EXPRESSION PROFILE OF LEUKEMIC CELLS 125
BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia 111
Casein kinase 1: A new tale of chronic lymphocytic leukemia (CLL) microenvironment 76
Indoleamine 2, 3-Dioxygenase 1 Mediates Survival Signals in Chronic Lymphocytic Leukemia via Kynurenine/Aryl Hydrocarbon Receptor-Mediated MCL1 Modulation 73
Casein kinase 1: A new tale of chronic lymphocytic leukemia (CLL) microenvironment 42
Totale 4.701
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.362
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.362
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019251 0 0 0 0 0 0 0 0 0 0 113 138
2019/20201.072 62 40 20 56 99 149 231 130 106 59 72 48
2020/20211.111 87 57 71 145 200 99 79 97 43 100 58 75
2021/2022628 52 55 49 28 22 57 26 32 62 56 119 70
2022/2023729 77 96 58 74 95 90 10 84 76 5 30 34
2023/2024365 15 19 27 56 80 49 41 65 6 7 0 0
Totale 4.701